Prostate Cancer Medical Websites: Friend Or Foe?
NEW YORK, Nov. 16, 2012 /PRNewswire/ -- Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
For world-renowned robotic prostate cancer surgeon, David Samadi, MD, the disease he treats – prostate cancer – and his technique are not simple. His global "treat and teach" philosophy centers on the most advanced prostate cancer treatment available, supported by thorough patient education. As such, he has two websites, www.roboticoncology.com and www.smart-surgery.com, that provide an overview of the disease, the full range of treatment options, and his own SMART (Samadi Modified Advanced Robotic Technique) surgery.
"Thorough and accurate patient education is vital," Dr. Samadi says. "I'm a robotic surgeon, but it's important for my patients to understand all options. I work to maintain websites that are clear and up-to-date so when patients leave my office – or before they even arrive – they have solid resources they can understand and depend on."We're often reminded to choose wisely when it comes to digging for medical information online. According to a Loyola University Medical Center study, however, it isn't just about being a savvy surfer. In some cases, you may need a medical degree to know what you're ready. Who's Online?
An Internet study by Pew Research Center suggests that most men of prostate cancer age are online and are looking for health information. Eighty-five percent of adults age 50-64 use the Internet, plus 58 percent of those over 65. Among them, 80 percent are gathering health and medical information.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV